GLORIA

GEOMAR Library Ocean Research Information Access

X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Data_Sheet_1.zip
    Frontiers Media SA ; 2022
    In:  Frontiers in Medicine Vol. 9 ( 2022-12-1)
    Details
    In: Frontiers in Medicine, Frontiers Media SA, Vol. 9 ( 2022-12-1)
    Abstract: Uremic pruritus causes sleep disturbances, poor quality of life, and increased morbidity in patients with chronic kidney disease. Acupuncture has been shown to improve uremic pruritus. There is limited evidence of the efficacy of traditional Chinese therapies. We conducted a systematic review and meta-analysis to evaluate the efficacy of acupoint stimulation therapy in patients with uremic pruritus. Methods A systematic search of seven databases (up to Sep 2022) was conducted for randomized controlled trials that evaluated the clinical efficacy of acupuncture, acupressure, auricular acupressure, acupoint injection, acupoint thermal therapy, acupoint sticking therapy, or transcutaneous electrical acupoint stimulation in the treatment of patients with uremic pruritus. Two reviewers selected eligible articles for inclusion in the meta-analysis and evaluated the risk of bias via Cochrane Collaboration. The results of pruritus assessments and uremic pruritus-related laboratory parameters were analyzed. Results Forty trials published between 2002 and 2022, including a total of 2,735 participants, were identified for inclusion in the meta-analysis. The effective rates for acupuncture, auricular acupressure, and the combination of acupoint injection and acupoint massage were significantly greater in patients with uremic pruritus compared to the control group. The levels of serum BUN, PTH, and histamine levels were significantly lower vs. control group. Conclusions Acupuncture, auricular acupressure, and the combination of acupoint injection and acupoint massage seem to be effective in improving uremic pruritus in patients with chronic kidney disease. However, further investigation of these potential treatments is now warranted in larger patient populations and over a longer time frame. Systematic review registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022354585 , identifier: PROSPERO CRD42022354585.
    Type of Medium: Online Resource
    ISSN: 2296-858X
    URL: Article
    URL: Article
    DOI: 10.3389/fmed.2022.1036072
    DOI: 10.3389/fmed.2022.1036072.s001
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2022
    detail.hit.zdb_id: 2775999-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 2
    Online Resource
    Online Resource
    Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
    MDPI AG ; 2021
    In:  Toxins Vol. 13, No. 11 ( 2021-10-30), p. 769-
    Details
    In: Toxins, MDPI AG, Vol. 13, No. 11 ( 2021-10-30), p. 769-
    Abstract: Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate the efficacy of intravenous sodium thiosulfate in patients with uremic pruritus. A systematic search of electronic databases up to June 2021 was conducted for randomized controlled trials that evaluated the clinical effects of sodium thiosulfate in the management of patients with uremic pruritus. Two reviewers selected eligible articles and evaluated the risk of bias; the results of pruritus assessment and uremic pruritus-related laboratory parameters in selected studies were analyzed. There are four trials published between 2018 and 2021, which include 222 participants. The sodium thiosulfate group displayed significant decrease in the pruritus score (standardized mean difference = −3.52, 95% confidence interval = −5.63 to −1.41, p = 0.001), without a significant increase in the adverse effects (risk ratio = 2.44, 95% confidence interval = 0.37 to 15.99, p = 0.35) compared to the control group. Administration of sodium thiosulfate is found to be a safe and efficacious complementary therapy in improving uremic pruritus in patients with chronic kidney disease.
    Type of Medium: Online Resource
    ISSN: 2072-6651
    URL: Article
    DOI: 10.3390/toxins13110769
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2518395-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 3
    Online Resource
    Online Resource
    Effects of Uremic Clearance Granules in Uremic Pruritus: A Meta-Analysis
    MDPI AG ; 2021
    In:  Toxins Vol. 13, No. 10 ( 2021-10-04), p. 702-
    Details
    In: Toxins, MDPI AG, Vol. 13, No. 10 ( 2021-10-04), p. 702-
    Abstract: Uremic pruritus is common among patients with advanced or end-stage renal disease, with an incidence of 〉 40% among patients on dialysis. Uremic clearance granules (UCGs) are effective in managing uremic pruritus and delay the progression of chronic kidney disease. We conducted a systematic review and a meta-analysis to evaluate the efficacy of UCG in patients with uremic pruritus. Several electronic databases were searched systematically from their inceptions until 19 July 2021. Randomized control trials evaluating the efficacy of UCG in patients with uremic pruritus were selected. Eleven trials including 894 participants were published between 2011 and 2021. Patients administered UCGs had a significantly decreased visual analog scale score (mean difference [MD], −2.02; 95% confidence interval [CI] , −2.17 to −1.88), serum levels of hsCRP (MD, −2.07 mg/dL; 95% CI, −2.89 to −1.25; p 〈 0.00001), TNF-α (MD, −15.23 mg/L; 95% CI, −20.00 to −10.47; p 〈 0.00001]), β2-MG (MD, −10.18 mg/L; 95% CI, −15.43 to −4.93; p 〈 0.00001), and IL-6 (MD, −6.13 mg/L; 95% CI, −7.42 to −4.84; p 〈 0.00001). In addition, UCGs significantly reduced serum levels of creatinine, BUN, PTH, iPTH, phosphorus, and the overall effectiveness rate. UCGs could be an attractive complementary therapy for patients with uremic pruritus.
    Type of Medium: Online Resource
    ISSN: 2072-6651
    URL: Article
    DOI: 10.3390/toxins13100702
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2518395-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 4
    Online Resource
    Online Resource
    Anti-transcription intermediary factor 1-γ neuromyositis: A case report
    Medknow ; 2023
    In:  Dermatologica Sinica Vol. 41, No. 1 ( 2023), p. 42-
    Details
    In: Dermatologica Sinica, Medknow, Vol. 41, No. 1 ( 2023), p. 42-
    Type of Medium: Online Resource
    ISSN: 1027-8117
    URL: Article
    DOI: 10.4103/ds.DS-D-22-00078
    Language: English
    Publisher: Medknow
    Publication Date: 2023
    detail.hit.zdb_id: 2556793-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 5
    Online Resource
    Online Resource
    41267 Acupuncture Point Stimulation Treatments as Adjuvant Therapy of Uremic Pruritus: A Systematic Review and Network Meta-analysis
    Elsevier BV ; 2023
    In:  Journal of the American Academy of Dermatology Vol. 89, No. 3 ( 2023-09), p. AB3-
    Details
    In: Journal of the American Academy of Dermatology, Elsevier BV, Vol. 89, No. 3 ( 2023-09), p. AB3-
    Type of Medium: Online Resource
    ISSN: 0190-9622
    URL: Article
    DOI: 10.1016/j.jaad.2023.07.023
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2023
    detail.hit.zdb_id: 2001404-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 6
    Online Resource
    Online Resource
    Should anti-tuberculosis therapy be prescribed in erythema induratum? A case-controlled and incidence correlation study between 2001 to 2020 in Taiwan
    Oxford University Press (OUP) ; 2024
    In:  Clinical and Experimental Dermatology ( 2024-02-06)
    Details
    In: Clinical and Experimental Dermatology, Oxford University Press (OUP), ( 2024-02-06)
    Abstract: Erythema induratum (EI) is a tuberculid associated with Mycobacterium tuberculosis (TB) infection. TB has been identified in Taiwan with a high percentage of EI using PCR. However, this pathogen has rarely been detected recently. Objective To explore the association between EI, annual incidence of tuberculosis in Taiwan, and treatment outcomes over the past two decades. Methods Patients diagnosed with EI between 2001 and 2020 were enrolled based on histopathology, tissue culture, and TB-PCR tests. Other cases of panniculitis with TB-PCR results were used as controls. Their clinical information was obtained. The results were correlated with the annual incidence of tuberculosis and compared between groups. Results Fifty-five specimens from EI patients fulfilled the inclusion criteria; three (3/55, 5%) had positive TB PCR. One patient diagnosed with erythema nodosum in the control group had positive TB PCR (1/27, 4%). There was no significant relationship between TB and EI (odds ratio = 1.5, 95% confidence interval = -0.964 to 3.964, p = 1). Correlation between the incidence of TB and number of EI cases was not significant (r = -0.185, p = 0.447). Only four patients received anti-tuberculosis therapy. They all showed clinical improvement without recurrence. One patient with PCR-positive EI was not treated with anti-tuberculosis therapy; however, the skin lesion improved 3 months later. No other patients in the EI group were diagnosed with TB infection in the follow up of 508 person-years. Conclusions Most EI in Taiwan are nodular vasculitis and not tuberculids owing to well-controlled tuberculosis. This condition can be alleviated without anti-tuberculosis therapy.
    Type of Medium: Online Resource
    ISSN: 0307-6938 , 1365-2230
    URL: Article
    DOI: 10.1093/ced/llae048
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2024
    detail.hit.zdb_id: 2004506-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 7
    Online Resource
    Online Resource
    Optical investigations of Berthelot-type properties in quaternary AlInGaN multiple quantum well heterosystems
    Elsevier BV ; 2009
    In:  Journal of Crystal Growth Vol. 311, No. 13 ( 2009-6), p. 3544-3548
    Details
    In: Journal of Crystal Growth, Elsevier BV, Vol. 311, No. 13 ( 2009-6), p. 3544-3548
    Type of Medium: Online Resource
    ISSN: 0022-0248
    URL: Article
    DOI: 10.1016/j.jcrysgro.2009.04.029
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2009
    detail.hit.zdb_id: 1466514-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 8
    Online Resource
    Online Resource
    Anomalous Optical Characteristics of Carrier Transfer Process in Quaternary AlInGaN Multiple Quantum Well Heterostructure
    IOP Publishing ; 2007
    In:  Japanese Journal of Applied Physics Vol. 46, No. 4B ( 2007-4-24), p. 2558-2562
    Details
    In: Japanese Journal of Applied Physics, IOP Publishing, Vol. 46, No. 4B ( 2007-4-24), p. 2558-2562
    Type of Medium: Online Resource
    ISSN: 0021-4922 , 1347-4065
    URL: Article
    DOI: 10.1143/JJAP.46.2558
    RVK:
    UA 4210.1
    RVK:
    UA 4210.2
    RVK:
    UA 4210
    Language: English
    Publisher: IOP Publishing
    Publication Date: 2007
    detail.hit.zdb_id: 218223-3
    detail.hit.zdb_id: 797294-5
    detail.hit.zdb_id: 2006801-3
    detail.hit.zdb_id: 797295-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...